Table 1. Patient demographics.
Gender | 34 males, 25 females |
---|---|
Age (mean) | 63 |
LVEF (mean) | 0.60 |
HTN | 73% |
CAD | 34% |
DM | 24% |
BB | 34% |
PHx of CHF | 8% (three diastolic, two systolic patients) |
RAN dose (mean) | 866 mg daily |
Time in between Holters (mean) | 3.10 mo |
Symptoms | |
Palpitations | 100% |
Dizziness | 65% |
Fatigue | 33% |
Abbreviations: BB, beta blocker; CAD, coronary artery disease; CHF, congestive heart failure; DM, type 2 diabetes; HTN, hypertension; LVEF, left ventricular ejection fraction; PHx, past history; RAN, ranolazine.